0000875320-24-000002.txt : 20240104
0000875320-24-000002.hdr.sgml : 20240104
20240104161723
ACCESSION NUMBER: 0000875320-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGNER CHARLES F JR
CENTRAL INDEX KEY: 0001223348
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 24512144
MAIL ADDRESS:
STREET 1: C/O MILLIPORE CORP
CITY: BILLERICA
STATE: MA
ZIP: 01820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wk-form4_1704403018.xml
FORM 4
X0508
4
2024-01-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001223348
WAGNER CHARLES F JR
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & Chief Financial Officer
1
Common Stock
2024-01-02
4
S
0
3000
405
D
43693
D
Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/18/2023.
/s/ Christiana Stevenson, Attorney-in-Fact
2024-01-04